Atara biotherapeutics to announce second quarter 2023 financial results on tuesday, august 8, 2023

Thousand oaks, calif.--(business wire)---- $atra #cart--atara biotherapeutics, inc. (nasdaq: atra), a leader in t-cell immunotherapy, leveraging its novel allogeneic epstein-barr virus (ebv) t-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced the company will release second quarter 2023 financial results after market close on tuesday, august 8, 2023. about atara biotherapeutics, inc. atara is harnessing the natural power of the immune system to.
ATRA Ratings Summary
ATRA Quant Ranking